Drug
Gcmaf a universal cancer cure?
A comment piece citing studies by Nobuto Yamamoto that report GcMAF, a vitamin D3-binding protein tied to macrophage activation, cured all 16 metastatic prostate cancer patients in a Translational Oncology paper with no recurrence for seven years. It argues immunotherapy avoids drug resistance.
2 min read